Calviri
Phoenix, US · Founded 2015 · Delaware corporation
Biotech
Founders & leadership
SA
Stephen Albert JohnstonExecutive Officer, Director
KS
Kathryn SykesDirector
GP
George PosteDirector
NW
Neal WoodburyDirector
AB
Anna BarkerDirector
JJ
Jacque J. SokolovDirector
MM
Michael McCallisterDirector
JL
Jeffrey Le BengerDirector
Reported raises · per SEC filings
Form D private placements▶$785KraisedNov 2024 · 10 investors · BiotechnologyRule 506(b)
▶$785KraisedNov 2024 · 10 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Kathryn SykesDirector
- Jeffrey Le BengerDirector
- Michael McCallisterDirector
- Stephen Albert JohnstonExecutive Officer, Director
- Jacque J. SokolovDirector
- Offering amount
- $5M
- Amount sold
- $785K
- Minimum investment
- $25K
- First sale
- Oct 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$150KraisedSep 2024 · 1 investors · BiotechnologyRule 506(b)
▶$150KraisedSep 2024 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Stephen Albert JohnstonExecutive Officer, Director
- Jacque J. SokolovDirector
- Michael McCallisterDirector
- Jeffrey Le BengerDirector
- Kathryn SykesDirector
- Offering amount
- $2M
- Amount sold
- $150K
- Minimum investment
- $25K
- First sale
- Sep 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$650.2KraisedOct 2023 · 3 investors · BiotechnologyRule 506(b)
▶$650.2KraisedOct 2023 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Stephen Albert JohnstonExecutive Officer, Director
- Jacque J. SokolovDirector
- Jeffrey Le BengerDirector
- Michael ChambersDirector
- Kathryn SykesDirector
- Michael McCallisterDirector
- Offering amount
- $30M
- Amount sold
- $650.2K
- Minimum investment
- $10K
- First sale
- Sep 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$11.1MraisedMay 2023 · 32 investors · BiotechnologyRule 506(b)
▶$11.1MraisedMay 2023 · 32 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jacque J. SokolovDirector
- Michael McCallisterDirector
- Stephen Albert JohnstonExecutive Officer, Director
- Jeff Le BengerDirector
- Michael ChambersDirector
- Kathryn SykesDirector
- Offering amount
- $11.1M
- Amount sold
- $11.1M
- Minimum investment
- $25K
- First sale
- Oct 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.4MraisedOct 2020 · 5 investors · BiotechnologyRule 506(b)
▶$2.4MraisedOct 2020 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Kathryn SykesDirector
- Stephen Albert JohnstonExecutive Officer, Director
- Michael ChambersDirector
- Michael McCallisterDirector
- Jacque J. SokolovDirector
- Offering amount
- $5M
- Amount sold
- $2.4M
- Minimum investment
- $25K
- First sale
- Sep 2020
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$430KraisedOct 2020 · 3 investors · BiotechnologyRule 506(b)
▶$430KraisedOct 2020 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Kathryn SykesDirector
- Stephen Albert JohnstonExecutive Officer, Director
- Jacque J. SokolovDirector
- Michael ChambersDirector
- Michael McCallisterDirector
- Offering amount
- $5M
- Amount sold
- $430K
- Minimum investment
- $25K
- First sale
- Sep 2020
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$1.9MraisedMar 2020 · 4 investors · BiotechnologyRule 506(b)
▶$1.9MraisedMar 2020 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- George PosteDirector
- Stephen Albert JohnstonExecutive Officer, Director
- Kathryn SykesDirector
- Neal WoodburyDirector
- Jacque J. SokolovDirector
- Anna BarkerDirector
- Offering amount
- $2.3M
- Amount sold
- $1.9M
- Minimum investment
- $25K
- First sale
- Dec 2018
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2019 | $299.6K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.